Bioluminescence Imaging-Based Assessment of the Anti-Triple-Negative Breast Cancer and NF-Kappa B Pathway Inhibition Activity of Britanin

Bioluminescence Imaging-Based Assessment of the Anti-Triple-Negative Breast Cancer and NF-Kappa B Pathway Inhibition Activity of Britanin

Britanin has been reported to have therapeutic effects on neurodegenerative and inflammation-based diseases. However, whether it is involved in the regulation of triple-negative breast cancer development has not been elucidated. In this study, we investigated the anti-tumor activity against triple-n...

Full description

Bibliographic Details
Main Authors: Xinyi Xu, Yingying Guo, Getao Du, Huifang Liu, Lin Wang, Dan Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Pharmacology
Subjects:
bioluminescence imaging
Britanin
triple-negative breast cancer
phytochemical
nuclear factor-kappa B pathway
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.00575/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.00575/full

Similar Items